Gabapentin for the treatment of hemifacial spasm

Clinical Neuropharmacology

Volumn 19, Issue 2, 1996, Pages 185-188

  Patel, Jayantibhai ^a   Naritoku, Dean K ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticonvulsant; Gabapentin; Hemifacial spasm

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; BACLOFEN; GABAPENTIN;

ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; CASE REPORT; DROWSINESS; EYELID MOVEMENT; FEMALE; HEMIFACIAL SPASM; HUMAN; PRIORITY JOURNAL;

EID: 0029987053     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619020-00008     Document Type: Article

References (26)

1. Auger RG, Whisnant JP. Hemifacial spasm in Rochester and Olmsted county, Minnesota. 1960-1984. Arch Neurol 1990;47:1233-4.
2. Ehni A. Hemifacial spasm: review of 106 cases. Arch Neurol Psychiatry 1945;53:205-11.
3. Neilsen VK. Pathophysiology of hemifacial spasm: I. ephaptic transmission and ectopic excitation. Neurology 1984;34:418-26.
4. Kuroki A, Muller AR. Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochir 1994;126:149-57.
5. Esteban A, Moina-Negro P. Primary hemifacial spasm: a neurophysiological study. J Neurol Neurosurg Psychiatry 1986;49:58-63.
6. Moller AR. Hemifacial spasm: ephaptic transmission or hyperexcitability of the facial motor nucleus. Exp Neurol 1987;98:110-19.
7. Moller AR, Jannetta PJ. Physiological abnormalities in hemifacial spasm studied during microvascular decompression operations. Exp Neurol 1986;93:584-600.
8. Alexander GE, Moses H III. Carbamazepine for hemifacial spasm. Neurology 1982;32:286-7.
9. Sandyk R, Gillman MA. Baclofen in hemifacial spasm. Int J Neurosci 1987;33:261-4.
10. Hughes EC, Braekmann DE, Weinstein RC. Seventh nerve spasm: effect of modification of cholinergic balance. Otolaryngol Head Neck Surg 1980;88:491-9.
11. Herzberg L. Management of hemifacial spasm with clonazepam. Neurology 1985;35:1976-7.
12. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 1994;35:181-8.
13. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol 1992;239:5-8.
14. Yoshimura DM, Aminoff MJ, Rami TA, Scott AB. Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992;15:1045-9.
15. Flanders M, Chin D, Boghen D. Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993;33:316-9.
16. Berardell A, Formica A, Mereuri B, et al. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multi-center study of the Italian Movement Disorder group, Ital J Neurol Sci 1993;14:361-7.
17. Airlanda P, Vita G, Micolosi C, Milone S, Mersina C. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992;55:844-5.
18. Loeser JD, Chen J. Hemifacial spasm: treatment by microsurgical facial nerve decompression. Neurosurgery 1983;13:141-6.
19. Auger RG, Pipegras DG, Laws GR Jr. Hemifacial spasm: results of microvascular decompression of the facial nerve in 54 patients. Mayo Clin Proc 1986;61:640-4.
20. Colbassani H Jr, Tindall GT, Tindall SC. Evaluation and treatment of hemifacial spasm. J Med Assoc Ga 1985;74:576-8.
21. Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg 1977;47:321-8.
22. Hanakita J, Kondo A. Serious complications of microvascular decompression operations for trigeminal neuralgia and hemifacial spasm. Neurosurgery 1988;22:348-52.
23. Wamil AW, McLean MJ. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res 1994;17:1-11.
24. Kondo T, Fromm G, Schmidt B. Comparison of gabapentin with other antiepileptic and GABAergic drugs. Epilepsy Res 1991;8:226-31.
25. McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology 1994;44(suppl 5):S17-22.
26. The U.S. Gabapentin Study Group. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo controlled, parallel-group study. Neurology 1993;43:2292-8.